MARGARET COLSON: Open Payments
NPI 1699346585 · POULSBO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 28 payments from 8 companies in 2025. Trend: 2023 $871 · 2024 $539 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $152 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| ABBVIE INC. | 8 | $143 |
| Janssen Biotech, Inc. | 2 | $41 |
| MERZ NORTH AMERICA, INC. | 1 | $30 |
| GENZYME CORPORATION | 1 | $26 |
| Lilly USA, LLC | 1 | $19 |
| Biofrontera Inc. | 1 | $15 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, NEMLUVIO, LIBTAYO, BOTOX, DYSPORT.
Industry payments across WA — which companies pay providers there.
